BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 22251899)

  • 1. Methamphetamine: history, pathophysiology, adverse health effects, current trends, and hazards associated with the clandestine manufacture of methamphetamine.
    Vearrier D; Greenberg MI; Miller SN; Okaneku JT; Haggerty DA
    Dis Mon; 2012 Feb; 58(2):38-89. PubMed ID: 22251899
    [No Abstract]   [Full Text] [Related]  

  • 2. Methamphetamine: history, pathophysiology, adverse health effects, current trends, and hazards associated with the clandestine manufacture of methamphetamine. Foreword.
    Leikin JB
    Dis Mon; 2012 Feb; 58(2):37. PubMed ID: 22251898
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical effects and management of methamphetamine abuse.
    Romanelli F; Smith KM
    Pharmacotherapy; 2006 Aug; 26(8):1148-56. PubMed ID: 16863490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mephedrone].
    Bertrand X; Gensburger M; Steckx E
    Rev Med Liege; 2011 Oct; 66(10):540-4. PubMed ID: 22141261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meth--it's everybody's problem.
    Harris MH
    S D J Med; 2003 Sep; 56(9):375-6. PubMed ID: 14524136
    [No Abstract]   [Full Text] [Related]  

  • 6. Designer drugs: a medicinal chemistry perspective.
    Carroll FI; Lewin AH; Mascarella SW; Seltzman HH; Reddy PA
    Ann N Y Acad Sci; 2012 Feb; 1248():18-38. PubMed ID: 22092008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The environmental impact and adverse health effects of the clandestine manufacture of methamphetamine.
    Irvine GD; Chin L
    NIDA Res Monogr; 1991; 115():33-46. PubMed ID: 1758481
    [No Abstract]   [Full Text] [Related]  

  • 8. Methamphetamine and its impact on dental care.
    Klasser GD; Epstein J
    J Can Dent Assoc; 2005 Nov; 71(10):759-62. PubMed ID: 16324229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Current data on methamphetamine].
    Cottencin O; Rolland B; Guardia D; Karila L
    Rev Prat; 2012 May; 62(5):679-81. PubMed ID: 22730802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The epidemiology of methamphetamine use and harm in Australia.
    Degenhardt L; Roxburgh A; Black E; Bruno R; Campbell G; Kinner S; Fetherston J
    Drug Alcohol Rev; 2008 May; 27(3):243-52. PubMed ID: 18368605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Major physical and psychological harms of methamphetamine use.
    Darke S; Kaye S; McKetin R; Duflou J
    Drug Alcohol Rev; 2008 May; 27(3):253-62. PubMed ID: 18368606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The meth menace: battling the fast-paced spread of methamphetamine may mean attacking it from several fronts.
    Boulard G
    State Legis; 2005 May; 31(5):14-8. PubMed ID: 15892208
    [No Abstract]   [Full Text] [Related]  

  • 13. Methamphetamine: geographic areas and populations at risk, and emerging evidence for effective interventions.
    Degenhardt L; Baker A; Maher L
    Drug Alcohol Rev; 2008 May; 27(3):217-9. PubMed ID: 18368601
    [No Abstract]   [Full Text] [Related]  

  • 14. Evidence of methamphetamine exposure in children removed from clandestine methamphetamine laboratories.
    Grant P; Bell K; Stewart D; Paulson J; Rogers K
    Pediatr Emerg Care; 2010 Jan; 26(1):10-4. PubMed ID: 20042914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The rise of methamphetamine in Southeast and East Asia.
    McKetin R; Kozel N; Douglas J; Ali R; Vicknasingam B; Lund J; Li JH
    Drug Alcohol Rev; 2008 May; 27(3):220-8. PubMed ID: 18368602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology of methamphetamine abuse in Missouri.
    Topolski JM
    Mo Med; 2007; 104(1):82-8. PubMed ID: 17410832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prevalence of methamphetamine and amphetamine abuse in North America: a review of the indicators, 1992-2007.
    Maxwell JC; Rutkowski BA
    Drug Alcohol Rev; 2008 May; 27(3):229-35. PubMed ID: 18368603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An evolving problem: methamphetamine production and trafficking in the United States.
    Shukla RK; Crump JL; Chrisco ES
    Int J Drug Policy; 2012 Nov; 23(6):426-35. PubMed ID: 22943831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of the clinical pharmacology of methamphetamine.
    Cruickshank CC; Dyer KR
    Addiction; 2009 Jul; 104(7):1085-99. PubMed ID: 19426289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DARK Classics in Chemical Neuroscience: Methamphetamine.
    Abbruscato TJ; Trippier PC
    ACS Chem Neurosci; 2018 Oct; 9(10):2373-2378. PubMed ID: 29602278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.